Testosterone deficiency-an underestimated risk for men? Prevalence of hypogonadism [Testosteronmangel -ein unterschätztes Risiko für Männer? Prävalenz des Hypogonadismus]

被引:0
作者
Jäger T. [1 ,2 ]
Kramer J. [3 ,4 ]
Bätz O. [3 ,4 ]
Rübben H. [2 ]
Von Ostau C. [1 ,2 ]
Szarvas T. [5 ]
机构
[1] Urologische Praxisklinik Essen UPK, Akademische Lehrpraxis der Medizinischen Fakultät, Universität Duisburg-Essen, Rüttenscheider Stern 5
[2] Klinik für Urologie, Universitätsklinikum Essen
[3] Labor Kramer, LADR GmbH Ihr Labor Vor Ort, MVZ Dr. Kramer and Kollegen, Geesthacht
[4] Medizinische Klinik i, Universität zu Lübeck
[5] Klinik für Urologie, Medizinische Universität Wien
来源
Der Urologe | 2013年 / 52卷 / 12期
关键词
Hypogonadism; Men's health; Prevalence; Syndrome; metabolic; Testosterone;
D O I
10.1007/s00120-013-3203-8
中图分类号
学科分类号
摘要
Background. Testosterone deficiency represents a significant health risk factor for men but the importance has so far been underestimated. Besides physiological and age-related reduction, acquired testosterone deficiency may also occur. Testosterone deficiency is a possible result of commonly occurring diseases or is itself the basis for development of different diseases. The scope of the present investigation was measurement of serum testosterone levels in different age groups.Materials and methods. Serum testosterone levels were determined in samples from 5,735 healthy men at the LADR laboratory MVZ Dr. Kramer & colleagues, Geesthacht under routine conditions. The frequency of testosterone deficiency was calculated in different age groups and compared using SPSS 19.0 software.Results. Pathologically low testosterone levels (<2.5 ng/ml) were found in 15.2% of subjectswhile 37.4% had a testosterone level lower than 3.5 ng/ml. Decreased testosterone levels were not associated with age. In addition the roportion of men with decreased serum testosterone levels was comparable in all age groups. The average serum testosterone level decreased slightly in all age groups during the period before midday.Conclusions. The data reveal high rates of testosterone deficiency in men independent of patient age. As decreased serum testosterone levels may be the consequence of several diseases and can be causally involved in the pathogenesis of further diseases, it is strongly recommended that serum testosterone measurement should be included in the diagnostic arsenal especially when symptoms, such as loss of libido, erectile dysfunction, lack of concentration, depression, lethargy, irritability and sleep disturbance are present. © Springer-Verlag Berlin Heidelberg 2013.
引用
收藏
页码:1684 / 1689
页数:5
相关论文
共 24 条
[1]  
Araujo, A.B., Wittert, G.A., Endocrinology of the aging male (2011) Best Pract Res Clin Endocrinol Metab, 25, pp. 303-319
[2]  
Kaufmann, J.M., Vermeulen, A., The decline of androgen levels in elderly men and its clinical and therapeutic implications (2005) Endocr Rev, 26, pp. 833-876
[3]  
Vermeulen, A., Kaufmann, J.M., Giagulli, V.A., Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males (1996) J Clin Endocrinol Metab, 81, pp. 1821-1826
[4]  
Travison, T.G., Araujo, A.B., Kupelian, V., The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men (2007) J Clin Endocrinol Metab, 92, pp. 549-555
[5]  
Wu, F.C., Tajar, A., Pye, S.R., European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study (2008) J Clin Endocrinol Metab, 93, pp. 2737-2745
[6]  
Kalyani, R.R., Gavini, S., Dobs, A.S., Male hypogonadism in systemic disease (2007) Endocrinol Metab Clin North Am, 36, pp. 333-348
[7]  
Svatberg, J., Midtby, M., Bonaa, K.H., The associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromso study (2003) Eur J Endocrinol, 149, pp. 145-152
[8]  
Liu, P.Y., Handelsman, D.J., Androgen therapy in non-gonadal disease (2004) Testosterone - Action, Deficiency, Substitution, pp. 445-495. , Nieschlag E, Behre HM (eds Cambridge University Press, Cambridge
[9]  
Dandona, P., Rosenberg, M.T., A practical guide to male hypogonadism in the primary care setting (2010) Int J Clin Pract, 64, pp. 682-696
[10]  
Tenover, J.L., Male hormone replacement therapy including "andropause" (1998) Endocrinol Metab Clin North Am, 27, pp. 969-987